OPT Congress: Oligonucleotide & Precision TherapeuticsMarch 16 - 19, 2020 - Cambridge MA US
Cambridge Healthtech Institute
Bringing together leading discovery scientists, developers, CMC experts, regulatory specialists and technology providers, OPT Congress provides a unique opportunity to discuss advances in next-generation oligonucleotide therapies throughout the drug development process. Attend in 2020 to optimize your drug design, delivery and performance, accelerate time to market and achieve commercial success. Based on the resounding success of last year’s inaugural 2-day program dedicated to Oligonucleotide CMC & Regulatory Strategies we will once again be adding this content to complement our established Oligonucleotide Discovery and Delivery conference. In addition, we deliver two in-depth symposiums focusing on Rare Disease Drug Development and NEW for 2020: AI in Drug Discovery and Development.